Cell and Gene Therapy Manufacturing Market

Cell and Gene Therapy Manufacturing Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029

20.1%

CAGR (2023-2029)

6.3 USD Bn.

Market Size

306

Report Pages

131

Market Tables

Overview

Cell and Gene Therapy Manufacturing Market is anticipated to reach US$ 22.73 Bn by 2029 from US$ 6.30 Bn in 2022 at a CAGR of 20.10% during a forecast period.

Cell and Gene Therapy Manufacturing Market Overview

In cell therapy, cells are changed outside of the patient's body before being put back into the patient's body, allowing them to serve as living medication. Gene therapy involves deactivating, substituting, or introducing genes into human cells that are either inside or outside the human body. Gene therapy is used to treat a variety of chronic diseases in humans and animals. Gene and cell therapies are intended to prevent disease progression as well as reverse disease growth. To know about the Research Methodology :- Request Free Sample Report

Cell and Gene Therapy Manufacturing Market Dynamics

The rising prevalence of cancer and other target diseases, increasing spending in pharmaceutical R&D, investments in advanced technologies by CDMOs, and increased collaborations and agreements between pharmaceutical firms are driving growth in this market. The growing market for cell and gene therapies has resulted in several strategic alliances and the entry of several new players. As a result, a significant number of companies are working with contract manufacturers to produce their therapeutic agents.

The high operational costs associated with cell and gene therapy manufacturing, on the other hand, are expected to limit the market's growth during the forecast period.

COVID-19 Impact on the Cell and Gene Therapy Manufacturing Market

The ongoing COVID-19 pandemic has had a beneficial impact on the Cell and Gene Therapy Manufacturing Market. Several companies have increased their production capacity and created strategic collaborations to develop experimental treatments. This is in response to the urgent need for effective treatments and a vaccine to combat the disease.

By June 2021, more than 1,200 clinical studies throughout the world had been interrupted, according to GEP Worldwide. The stoppage of patient enrolment caused about 61 percent of clinical studies to be halted. The impact fluctuated throughout the year owing to variations in COVID-19 case numbers, but the worst effect was noticed in April 2021. During this period, trials in respiratory illness, cancer, ID/anti-infectives, and cardiovascular disease were the worst impacted.

Cell and Gene Therapy Manufacturing Market Segment Analysis

By Mode, in 2022, the in-house segment accounted for 85% of its total sales. A large number of capital firms and academic institutes with specific patient care programs make the biggest contribution to this segment. Greater flexibility in troubleshooting processes, supply chain control, and effective corporate knowledge generation are all major reasons driving growth in the segment.

Cell and Gene Therapy Manufacturing Market Regional Insights

North America accounted for 43.0 percent of overall sales in 2022. A substantial number of active clinical studies, as well as a growing commitment of firms to gene- and cell therapy R&D in the area, are driving market expansion. New product growth, partnership, strategic alliances, and licensing of medication and medicine patenting or trade copyrights have all aided regional market growth.

As part of the Horizon 2021 program, several new cooperative research and innovation initiatives have been launched across Europe. These initiatives include viral vector-based gene therapy trials for rare diseases. As a result, Cell and Gene Therapy Manufacturing Market is expected to grow across Europe during the forecast period. In addition, Asia Pacific countries are growing as major rivals in this market. The growth of Asian markets is being fueled by the introduction of faster approval routes, expanding private and government investments, and rising healthcare demands.

Cell and Gene Therapy Manufacturing Market Scope: Inquire before buying

Global Cell and Gene Therapy Manufacturing Market
Report Coverage	Details
Base Year:	2022	Forecast Period:	2023-2029
Historical Data:	2018 to 2022	Market Size in 2022:	US $ 6.30 Bn.
Forecast Period 2023 to 2029 CAGR:	20.1%	Market Size in 2029:	US $ 22.73 Bn.
Segments Covered:	by Therapy Type	Cell Therapy Manufacturing Gene Therapy Manufacturing
	by Scale	Pre-commercial/ R&D Scale Manufacturing Commercial Scale Manufacturing
	by Mode	Contract Manufacturing In-house Manufacturing
	by Workflow	Cell Processing Cell Banking Process Development Fill & Finish Operations Analytical and Quality Testing Raw Material Testing Vector Production Others

Cell and Gene Therapy Manufacturing Market by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Cell and Gene Therapy Manufacturing Market Key Players

1. Thermo Fisher Scientific
2. Merck KGaA
3. Lonza
4. Catalent Inc.
5. Takara Bio Inc.
6. F. Hoffmann-La Roche Ltd
7. Wuxi Advanced Therapies
8. Samsung Biologics
9. Boehringer Ingelheim
10.Novartis AG
11.Hitachi Chemical Co., Ltd.
12.Cellular Therapeutics
13.Miltenyi Biotec
14.Bluebird Bio Inc.
15.ElevateBio

Frequently Asked Questions:

1. Which region has the largest share in Global Cell and Gene Therapy Manufacturing Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Market?
Ans: The Global Market is expected to grow at a CAGR of 20.10% during forecast period 2023-2029.

3. What is scope of the Global market report?
Ans: Global Cell and Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global market?
Ans: The important key players in the Global Market are – , Thermo Fisher Scientific, Merck KGaA, Lonza, Catalent Inc., Takara Bio Inc., F. Hoffmann-La Roche Ltd, Wuxi Advanced Therapies, Samsung Biologics, Boehringer Ingelheim, Novartis AG, Hitachi Chemical Co., Ltd., Cellular Therapeutics, Miltenyi Biotec, Bluebird Bio Inc., and ElevateBio.

5. What is the study period of this market?
Ans: The Global Market is studied from 2022 to 2029.

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Cell and Gene Therapy Manufacturing Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Cell and Gene Therapy Manufacturing Market 3.4. Geographical Snapshot of the Cell and Gene Therapy Manufacturing Market, By Manufacturer share 4. Cell and Gene Therapy Manufacturing Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Cell and Gene Therapy Manufacturing Market 5. Supply Side and Demand Side Indicators 6. Cell and Gene Therapy Manufacturing Market Analysis and Forecast, 2022-2029 6.1. Cell and Gene Therapy Manufacturing Market Size & Y-o-Y Growth Analysis. 7. Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2022-2029 7.1.1. Cell Therapy Manufacturing 7.1.2. Gene Therapy Manufacturing 7.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 7.2.1. Pre-commercial/ R&D Scale Manufacturing 7.2.2. Commercial Scale Manufacturing 7.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 7.3.1. Contract Manufacturing 7.3.2. In-house Manufacturing 7.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 7.4.1. Cell Processing 7.4.2. Cell Banking 7.4.3. Process Development 7.4.4. Fill & Finish Operations 7.4.5. Analytical and Quality Testing 7.4.6. Raw Material Testing 7.4.7. Vector Production 7.4.8. Others 8. Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 9.1.1. Cell Therapy Manufacturing 9.1.2. Gene Therapy Manufacturing 9.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 9.2.1. Pre-commercial/ R&D Scale Manufacturing 9.2.2. Commercial Scale Manufacturing 9.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 9.3.1. Contract Manufacturing 9.3.2. In-house Manufacturing 9.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 9.4.1. Cell Processing 9.4.2. Cell Banking 9.4.3. Process Development 9.4.4. Fill & Finish Operations 9.4.5. Analytical and Quality Testing 9.4.6. Raw Material Testing 9.4.7. Vector Production 9.4.8. Others 10. North America Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 11.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 11.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 12. Canada Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 12.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 12.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 13. Mexico Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 13.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 13.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 14. Europe Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 14.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 14.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 15. Europe Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 16.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 16.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 17. France Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 17.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 17.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 18. Germany Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 18.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 18.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 19. Italy Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 19.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 19.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 20. Spain Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 20.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 20.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 21. Sweden Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 21.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 21.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 22. CIS Countries Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 22.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 22.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 23. Rest of Europe Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 23.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 23.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 24. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 24.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 24.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 25. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 26.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 26.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 27. India Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 27.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 27.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 28. Japan Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 28.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 28.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 29. South Korea Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 29.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 29.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 30. Australia Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 30.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 30.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 31. ASEAN Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 31.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 31.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 32. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 32.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 32.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 33. Middle East Africa Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 33.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 33.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 34. Middle East Africa Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 35.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 35.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 36. GCC Countries Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 36.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 36.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 37. Egypt Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 37.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 37.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 38. Nigeria Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 38.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 38.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 39. Rest of ME&A Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 39.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 40. South America Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 40.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 41. South America Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 42.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 42.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 43. Argentina Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 43.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 43.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 44. Rest of South America Cell and Gene Therapy Manufacturing Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Therapy Type,2022-2029 44.2. Market Size (Value) Estimates & Forecast By Scale, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By Mode, 2022-2029 44.4. Market Size (Value) Estimates & Forecast By Workflow, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Cell and Gene Therapy Manufacturing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of key players By Scale, presence, market share, Applications and R&D investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Applications 45.2.3.2. M&A Key Players, Forward Integration and Backward Integration 45.3. Company Profile: Key Players 45.3.1. Lonza 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.4. Thermo Fisher Scientific 45.5. Merck KGaA 45.6. Lonza 45.7. Catalent Inc. 45.8. Takara Bio Inc. 45.9. F. Hoffmann-La Roche Ltd 45.10. Wuxi Advanced Therapies 45.11. Samsung Biologics 45.12. Boehringer Ingelheim 45.13. Novartis AG 45.14. Hitachi Chemical Co., Ltd. 45.15. Cellular Therapeutics 45.16. Miltenyi Biotec 45.17. Bluebird Bio Inc. 45.18. ElevateBio

Global Cell and Gene Therapy Manufacturing Market

Choose License Type